Stay updated on Nivolumab Post Induction in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post Induction in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Updated operating-status notice and version to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:49:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Updated contact details and updated revision to v3.1.0; removed old revision v3.0.2.
    Difference
    0.1%
    Check dated 2025-09-29T03:10:48.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page revision updates from v3.0.1 to v3.0.2, and the 'Back to Top' element has been removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:53:24.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T16:51:40.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated to include a specific facility name and location in Goyang-si, Gyeonggi-do, South Korea, while removing several references to previous location terms and specific medical topics related to cancer treatment.
    Difference
    3%
    Check dated 2025-08-31T12:03:33.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:34:40.000Z thumbnail image

Stay in the know with updates to Nivolumab Post Induction in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post Induction in NSCLC Clinical Trial page.